Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Indian Journal of Clinical Biochemistry : IJCB
|
October 30, 2012
Antidyslipidemic and antioxidant activities of different fractions ofTerminalia arjuna stem bark
Ramesh Chander, Kavita Singh, A K Khanna, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
October 2, 2012
Improved agreement between experienced and inexperienced observers using a standardized evaluation protocol for cardiac volumetry and infarct size measurement
M Groth, K Muellerleile, T Klink, et al.
Neuroscience
|
August 12, 2000
Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury
M Li, V O Ona, M Chen, et al.
Cancer
|
October 1, 1991
A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer
M Büchler, H Friess, K H Schultheiss, et al.
Blood
|
August 1, 1995
Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)
E Holler, H J Kolb, J Mittermüller, et al.
Plos One
|
September 19, 2023
EquiPrEP: An implementation science protocol for promoting equitable access and uptake of long-acting injectable HIV pre-exposure prophylaxis (LAI-PrEP)
Christina M Kaul, Brandi E Moore, Emma Kaplan-Lewis, et al.
Critical Care Medicine
|
May 1, 1996
Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study
K Reinhart, C Wiegand-Löhnert, F Grimminger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 22, 2021
First-in-human study demonstrating the safety and clinical efficacy of novel anti-IL-17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis
M Kaul, P Jarvis, I Rozenberg, et al.
Critical Care Medicine
|
May 25, 2001
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study
K Reinhart, T Menges, B Gardlund, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2021
First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis
L A Emens, S Adams, C H Barrios, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Indian Journal of Clinical Biochemistry : IJCB
|
October 30, 2012
Antidyslipidemic and antioxidant activities of different fractions ofTerminalia arjuna stem bark
Ramesh Chander, Kavita Singh, A K Khanna, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
October 2, 2012
Improved agreement between experienced and inexperienced observers using a standardized evaluation protocol for cardiac volumetry and infarct size measurement
M Groth, K Muellerleile, T Klink, et al.
Neuroscience
|
August 12, 2000
Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury
M Li, V O Ona, M Chen, et al.
Cancer
|
October 1, 1991
A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer
M Büchler, H Friess, K H Schultheiss, et al.
Blood
|
August 1, 1995
Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)
E Holler, H J Kolb, J Mittermüller, et al.
Plos One
|
September 19, 2023
EquiPrEP: An implementation science protocol for promoting equitable access and uptake of long-acting injectable HIV pre-exposure prophylaxis (LAI-PrEP)
Christina M Kaul, Brandi E Moore, Emma Kaplan-Lewis, et al.
Critical Care Medicine
|
May 1, 1996
Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study
K Reinhart, C Wiegand-Löhnert, F Grimminger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 22, 2021
First-in-human study demonstrating the safety and clinical efficacy of novel anti-IL-17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis
M Kaul, P Jarvis, I Rozenberg, et al.
Critical Care Medicine
|
May 25, 2001
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study
K Reinhart, T Menges, B Gardlund, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2021
First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis
L A Emens, S Adams, C H Barrios, et al.
Page
of 10